IP Verse

Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S - IPR2023-00723

Explore the PTAB proceeding IPR2023-00723 filed by Mylan Pharmaceuticals Inc. et al. against Novo Nordisk A/S on Mar 16, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-00723
Filing Date
Mar 16, 2023
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Novo Nordisk A/S
Status
Institution Denied
Respondent Application Number
11908834
Respondent Tech Center
1600
Respondent Patent Number
8129343
Institution Decision Date
Oct 2, 2023
Termination Date
Oct 2, 2023

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2023-00723.

TypeName
Petitioner CounselWhite, Brandonet al
Respondent CounselBaughman, Jonet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.